These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 3032791

  • 1. Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats.
    Schiffrin EL, St-Louis J.
    Hypertension; 1987 May; 9(5):504-12. PubMed ID: 3032791
    [Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
    Nuglozeh E, Gauquelin G, Garcia R, Tremblay J, Schiffrin EL.
    Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357
    [Abstract] [Full Text] [Related]

  • 3. [The changes in natriuretic peptide receptors (NP-R) in the lung and kidney in DOCA-salt hypertensive rats].
    Liu LM, Yoshimi T.
    Nihon Naibunpi Gakkai Zasshi; 1995 May 20; 71(4):587-96. PubMed ID: 7796923
    [Abstract] [Full Text] [Related]

  • 4. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H.
    Circulation; 1993 Feb 20; 87(2):554-61. PubMed ID: 8381060
    [Abstract] [Full Text] [Related]

  • 5. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H, Nakao K, Mukoyama M, Yamada T, Hosoda K, Shirakami G, Morii N, Sugawara A, Saito Y, Shiono S.
    J Clin Invest; 1989 Jul 20; 84(1):145-54. PubMed ID: 2544622
    [Abstract] [Full Text] [Related]

  • 6. Regulation of receptors for atrial natriuretic peptide in the rat and human.
    Schiffrin EL.
    Cardiovasc Drugs Ther; 1988 Nov 20; 2(4):493-500. PubMed ID: 2856469
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II and atrial natriuretic factor-binding sites in various tissues in hypertension: comparative receptor localization and changes in different hypertension models in the rat.
    Wilson SK, Lynch DR, Ladenson PW.
    Endocrinology; 1989 Jun 20; 124(6):2799-808. PubMed ID: 2542000
    [Abstract] [Full Text] [Related]

  • 8. Vascular receptors for atrial natriuretic peptide in hypertension.
    Schiffrin EL.
    Int J Rad Appl Instrum B; 1990 Jun 20; 17(7):673-6. PubMed ID: 2175736
    [Abstract] [Full Text] [Related]

  • 9. Vascular receptors for angiotensin, vasopressin, and atrial natriuretic peptide in experimental hypertension.
    Schiffrin EL.
    Can J Physiol Pharmacol; 1989 Sep 20; 67(9):1118-23. PubMed ID: 2557150
    [Abstract] [Full Text] [Related]

  • 10. Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody.
    Itoh H, Nakao K, Mukoyama M, Arai H, Yamada T, Saito Y, Shiono S, Hosoda K, Shirakami G, Suga S.
    Am J Hypertens; 1991 Jan 20; 4(1 Pt 1):39-44. PubMed ID: 1706603
    [Abstract] [Full Text] [Related]

  • 11. Phasic plasma atrial natriuretic polypeptide changes in DOCA-salt hypertensive rats.
    Sato Y, Ito Y, Ando K, Ogata E, Fujita T.
    Jpn Heart J; 1990 Sep 20; 31(5):703-11. PubMed ID: 2148777
    [Abstract] [Full Text] [Related]

  • 12. Computerized approach using autoradiography to quantify atrial natriuretic peptide receptors in the DOCA-salt hypertensive rat kidney.
    Takatori K, Ogura T, Ota Z.
    Regul Pept; 1991 Aug 13; 35(2):115-25. PubMed ID: 1661902
    [Abstract] [Full Text] [Related]

  • 13. Specific binding of atrial natriuretic factor to renal glomeruli in Doca- and Doca-salt-treated rats correlation with atrial and plasma levels.
    Gauquelin G, Schiffrin EL, Cantin M, Garcia R.
    Biochem Biophys Res Commun; 1987 May 29; 145(1):522-31. PubMed ID: 3036134
    [Abstract] [Full Text] [Related]

  • 14. Defective ANF-R2/ANP-C receptor-mediated signalling in hypertension.
    Marcil J, Anand-Srivastava MB.
    Mol Cell Biochem; 1995 May 29; 149-150():223-31. PubMed ID: 8569733
    [Abstract] [Full Text] [Related]

  • 15. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment.
    Lee YJ, Shin SJ, Tan MS, Hsieh TJ, Tsai JH.
    Am J Physiol; 1996 Oct 29; 271(4 Pt 2):F779-89. PubMed ID: 8898007
    [Abstract] [Full Text] [Related]

  • 16. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF, Jin HK, Paul R, Nagahama S.
    J Pharmacol Exp Ther; 1988 Aug 29; 246(2):485-92. PubMed ID: 2969976
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased plasma brain natriuretic peptide levels in DOCA-salt hypertensive rats: relation to blood pressure and cardiac concentration.
    Yokota N, Aburaya M, Yamamoto Y, Kato J, Kitamura K, Kida O, Eto T, Minamino N, Kangawa K, Matsuo H.
    Biochem Biophys Res Commun; 1990 Dec 14; 173(2):632-8. PubMed ID: 2148083
    [Abstract] [Full Text] [Related]

  • 19. Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension.
    Kohno M, Horio T, Yoshiyama M, Takeda T.
    Hypertension; 1992 Feb 14; 19(2):206-11. PubMed ID: 1531333
    [Abstract] [Full Text] [Related]

  • 20. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R, St-Louis J, Schiffrin EL.
    J Hypertens; 1988 Mar 14; 6(3):211-7. PubMed ID: 3283226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.